165 related articles for article (PubMed ID: 34984837)
21. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.
An Y; Jiang W; Andraos TY; Reddy JP; Yehia ZA; Lloyd S; Duvic M; D'Souza NM; Milgrom SA; Pinnix CC; Oki Y; Smith GL; Wilson LD; Dabaja BS
Radiother Oncol; 2019 Feb; 131():88-92. PubMed ID: 30773193
[TBL] [Abstract][Full Text] [Related]
22. Total Skin Electron Beam Therapy in the Treatment of Mycosis Fungoides: A Review of Conventional and Low-Dose Regimens.
Chowdhary M; Chhabra AM; Kharod S; Marwaha G
Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):662-671. PubMed ID: 27692530
[TBL] [Abstract][Full Text] [Related]
23. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation).
Ysebaert L; Truc G; Dalac S; Lambert D; Petrella T; Barillot I; Naudy S; Horiot JC; Maingon P
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1128-34. PubMed ID: 15001254
[TBL] [Abstract][Full Text] [Related]
24. Mycosis fungoides with spongiosis: a case report.
Kashabano JJ; Rugengamazi E; Matiku SB; Mruma RM; Lugina EL
J Med Case Rep; 2023 Nov; 17(1):458. PubMed ID: 37919795
[TBL] [Abstract][Full Text] [Related]
25. Low-dose total skin electron beam therapy as a debulking agent for cutaneous T-cell lymphoma: an open-label prospective phase II study.
Kamstrup MR; Lindahl LM; Gniadecki R; Iversen L; Skov L; Petersen PM; Loft A; Specht L
Br J Dermatol; 2012 Feb; 166(2):399-404. PubMed ID: 21967035
[TBL] [Abstract][Full Text] [Related]
26. Total skin electron beam therapy (TSEBT) in management of mycosis fungoides: A case series.
Abrar S; Qureshi BM; Hafiz A; Ali N; Hammad Khan AM; Abbasi AN
J Pak Med Assoc; 2022 Jun; 72(6):1208-1210. PubMed ID: 35751338
[TBL] [Abstract][Full Text] [Related]
27. Low-dose total skin electron beam therapy for cutaneous lymphoma : Minimal risk of acute toxicities.
Kroeger K; Elsayad K; Moustakis C; Haverkamp U; Eich HT
Strahlenther Onkol; 2017 Dec; 193(12):1024-1030. PubMed ID: 28785772
[TBL] [Abstract][Full Text] [Related]
28. Mogamulizumab and bexarotene are a promising association for the treatment of advanced cutaneous T-cell lymphomas: a case series.
Teoli M; Mandel VD; Franceschini C; Saraceni PL; Cicini MP; Ardigò M
Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):8118-8128. PubMed ID: 36394762
[TBL] [Abstract][Full Text] [Related]
29. Short-term efficacy and safety of total skin electron beam therapy in mycosis fungoides: Systematic review and meta-analysis.
Grandi V; Simontacchi G; Grassi T; Pileri A; Pimpinelli N
Dermatol Ther; 2022 Nov; 35(11):e15840. PubMed ID: 36124354
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
31. Acute toxicity and risk of infection during total skin electron beam therapy for mycosis fungoides.
Lloyd S; Chen Z; Foss FM; Girardi M; Wilson LD
J Am Acad Dermatol; 2013 Oct; 69(4):537-43. PubMed ID: 23849563
[TBL] [Abstract][Full Text] [Related]
32. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999.
Rampino M; Ragona R; Monetti U; Mussano A; Guarneri A; Sannazzari GL
Radiol Med; 2002; 103(1-2):108-14. PubMed ID: 11859306
[TBL] [Abstract][Full Text] [Related]
33. Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
Sokolowska-Wojdylo M; Florek A; Zaucha JM; Chmielowska E; Giza A; Knopinska-Posluszny W; Kulikowski W; Prejzner W; Romejko-Jarosinska J; Paszkiewicz-Kozik E; Osowiecki M; Walewski J; Rogowski W; Grzanka A; Placek W; Lugowska-Umer H; Kowalczyk A; Nowicki R; Jurczak W
Am J Ther; 2016; 23(3):e749-56. PubMed ID: 24732904
[TBL] [Abstract][Full Text] [Related]
34. Total skin electron beam therapy for cutaneous T-cell lymphoma: a nationwide cohort study from Denmark.
Lindahl LM; Kamstrup MR; Petersen PM; Wirén J; Fenger-Grøn M; Gniadecki R; Iversen L; Specht L
Acta Oncol; 2011 Nov; 50(8):1199-205. PubMed ID: 21736502
[TBL] [Abstract][Full Text] [Related]
35. Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center.
Flores-Balcázar C; Urías-Arce DM; Charli-Joseph Y; De León-Alfaro MA; Pérez-Álvarez SI; Ramos-Prudencio R
Rep Pract Oncol Radiother; 2020; 25(4):562-567. PubMed ID: 32494229
[TBL] [Abstract][Full Text] [Related]
36. [Long term results of total skin electron beam therapy (TSEBT) in the treatment of mycosis fungoides].
Hagedorn M; Hasche E; Kober B; Sander CA
Hautarzt; 2003 Mar; 54(3):256-64. PubMed ID: 12634995
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
Kannangara AP; Levitan D; Fleischer AB
J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
[TBL] [Abstract][Full Text] [Related]
38. Alitretinoin in the treatment of cutaneous T-cell lymphoma.
Kaemmerer T; Stadler PC; Helene Frommherz L; Guertler A; Einar French L; Reinholz M
Cancer Med; 2021 Oct; 10(20):7071-7078. PubMed ID: 34435474
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of low-dose bexarotene and PUVA in the treatment of patients with mycosis fungoides.
Papadavid E; Antoniou C; Nikolaou V; Siakantaris M; Vassilakopoulos TP; Stratigos A; Stavrianeas N; Katsambas A
Am J Clin Dermatol; 2008; 9(3):169-73. PubMed ID: 18429646
[TBL] [Abstract][Full Text] [Related]
40. Bexarotene and DAB(389)IL-2 (denileukin diftitox, ONTAK) in treatment of cutaneous T-cell lymphomas: algorithms.
Duvic M
Clin Lymphoma; 2000 Nov; 1 Suppl 1():S51-5. PubMed ID: 11707865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
